A modern understanding of IgA nephropathy and hemorrhagic vasculitis as tonsillogenic diseases and effects of tonsillectomy on their progression

Abstract

IgA nephropathy and hemorrhagic vasculitis are IgA-mediated meta-tonsillar diseases. The literature on their pathogenesis, association with chronic tonsillitis, and effects of tonsillectomy on their progression was reviewed. In patients with IgA nephropathy, tonsillectomy is associated with higher rates of clinical remission, suppressing progression of renal failure as a result of decreased mucosal production of abnormally galactosylated IgA1 molecules. This finding is supported by high-quality studies in Asian populations and isolated comparative studies in Caucasians. For this reason, Asian guidelines, especially Japanese, include tonsillectomy as a treatment option for this group of patients.

In hemorrhagic vasculitis, tonsillectomy is only effective in clinical forms with renal impairment. For other forms, symptomatic treatment is preferred, and tonsillectomy is indicated when there is a proven association between attacks of chronic tonsillitis and deterioration of kidney function. Further research is needed in this area with a larger population of patients with IgA-mediated diseases and with the ability to evaluate the impact of genetic characteristics on treatment outcome.

Keywords

chronic tonsillitis / tonsillectomy / IgA nephropathy / hemorrhagic vasculitis

References

[1] Pal’chun VT, Gurov AV, Guseva OA. The specific pathogenetic features of the development of chronic tonsillar pathology. Russian Bulletin of Otorhinolaryngology. 2018;83(2):30–33. EDN: XOBRHV doi: 10.17116/otorino201883230-33

[2] Пальчун В.Т., Гуров А.В., Гусева О.А. Патогенетические особенности формирования хронической тонзиллярной патологии // Вестник оториноларингологии. 2018. Т. 83, № 2. С. 30–33. EDN: XOBRHV doi: 10.17116/otorino201883230-33

[3] Karpishchenko SA, Svistushkin SM, editors. Chronic and acute tonsillitis. Immunological and clinical aspects. Saint Petersburg: Dialog; 2020. (In Russ.)

[4] Хронический тонзиллит и ангина. Иммунологические и клинические аспекты / под ред. С.А. Карпищенко, В.М. Свистушкина. Санкт-Петербург: Диалог, 2020.

[5] Karpishchenko SA, Lavrenova GV, Baranskaya SV. Tonsillitis and tonsillogenic conditions. Russian Bulletin of Otorhinolaryngology. 2016;81(4):69–71. EDN: WIAACR doi: 10.17116/otorino201681469-71

[6] Карпищенко С.А., Лавренова Г.В., Баранская С.В. Тонзиллит и тонзиллогенные заболевания // Вестник оториноларингологии. 2016. Т. 81, № 4. С. 69–71. EDN: WIAACR doi: 10.17116/otorino201681469-71

[7] Lavrenova GV, Nesterova KI, Yaremenko KV, Nesterova AA. The rationale for the conservative treatment of chronic tonsillitis in the patients of the older age groups by the “soft” therapy methods. Russian Bulletin of Otorhinolaryngology. 2016;81(4):22–26. EDN: WHZZYL doi: 10.17116/otorino201681422-26

[8] Лавренова Г.В., Нестерова К.И., Яременко К.В., Нестерова А.А. Обоснование консервативного лечения хронического тонзиллита у лиц старших возрастных групп методами «мягкой» терапии // Вестник оториноларингологии. 2016. Т. 81, № 4. С. 22–26. EDN: WHZZYL doi: 10.17116/otorino201681422-26

[9] Ștefan G, Zugravu A, Stancu S. Mortality in IgA nephropathy: a long-term follow-up of an Eastern European Cohort. Medicina (Kaunas). 2024;60(2):247. doi: 10.3390/medicina60020247

[10] Ștefan G., Zugravu A., Stancu S. Mortality in IgA nephropathy: a long-term follow-up of an Eastern European Cohort // Medicina (Kaunas). 2024. Vol. 60, N 2. P. 247. doi: 10.3390/medicina60020247

[11] Li M, Yu X-Q. Genetic determinants of IgA nephropathy: Eastern perspective. Semin Nephrol. 2018;38:455–460. doi: 10.1016/j.semnephrol.2018.05.015

[12] Li M., Yu X.-Q. Genetic determinants of IgA nephropathy: Eastern perspective // Semin Nephrol. 2018. Vol. 38, N 5. P. 455–460. doi: 10.1016/j.semnephrol.2018.05.015

[13] Novak J, Moldoveanu Z, Julian BA, et al. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: Role of Mucosal Immune System. Adv Otorhinolaryngol. 2011;72:60–63. doi: 10.1159/000324607

[14] Novak J., Moldoveanu Z., Julian B.A., et al. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system // Adv Otorhinolaryngol. 2011. Vol. 72. P. 60–63. doi: 10.1159/000324607

[15] Nihei Y, Suzuki H, Suzuki Y. Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy. Front Immunol. 2023;14:1165394. doi: 10.3389/fimmu.2023.1165394

[16] Nihei Y., Suzuki H., Suzuki Y. Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy // Front Immunol. 2023. Vol. 14. P. 1165394. doi: 10.3389/fimmu.2023.1165394

[17] Coppo R, Troyanov S, Bellur S, et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014;86(4):828–836. doi: 10.1038/ki.2014.63

[18] Coppo R., Troyanov S., Bellur S., et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments // Kidney Int. 2014. Vol. 86, N 4. P. 828–836. doi: 10.1038/ki.2014.63

[19] Takechi H, Oda T, Hotta O, et al. Clinical and immunological implications of increase in CD208+ dendritic cells in tonsils of patients with immunoglobulin a nephropathy. Nephrol Dial Transplant. 2013;28(12):3004–3013. doi: 10.1093/ndt/gft399

[20] Takechi H., Oda T., Hotta O., et al. Clinical and immunological implications of increase in CD208+ dendritic cells in tonsils of patients with immunoglobulin a nephropathy // Nephrol Dial Transplant. 2013. Vol. 28, N 12. P. 3004–3013. doi: 10.1093/ndt/gft399

[21] Harabuchi Y, Takahara M. Recent advances in the immunological understanding of association between tonsil and immunoglobulin a nephropathy as a tonsil-induced autoimmune/ inflammatory syndrome. Immun Inflamm Dis. 2019;7(2):86–92. doi: 10.1002/iid3.248

[22] Harabuchi Y., Takahara M. Recent advances in the immunological understanding of association between tonsil and immunoglobulin a nephropathy as a tonsil-induced autoimmune/inflammatory syndrome // Immun Inflamm Dis. 2019. Vol. 7, N 2. P. 86–92. doi: 10.1002/iid3.248

[23] Hotta O, Ieiri N, Nagai M, et al. Role of palatine tonsil and epipharyngeal lymphoid tissue in the development of glomerular active lesions (glomerular vasculitis) in immunoglobulin A nephropathy. Int J Mol Sci. 2022;23(2):727. doi: 10.3390/ijms23020727

[24] Hotta O., Ieiri N., Nagai M., et al. Role of palatine tonsil and epipharyngeal lymphoid tissue in the development of glomerular active lesions (glomerular vasculitis) in immunoglobulin A nephropathy // Int J Mol Sci. 2022. Vol. 23, N 2. P. 727. doi: 10.3390/ijms23020727

[25] Floege J, Rauen T, Tang SC. Current treatment of IGA nephropathy. Semin Immunopathol. 2021;43(5):717–728. doi: 10.1007/s00281-021-00888-3

[26] Floege J., Rauen T., Tang S.C. Current treatment of IGA nephropathy // Semin Immunopathol. 2021. Vol. 43, N 5. P. 717–728. doi: 10.1007/s00281-021-00888-3

[27] Teh J, Biswas K, Waldvogel-Thurlow S, et al. Paired qualitative and quantitative analysis of bacterial microcolonies in the tonsils of patients with tonsillar hyperplasia. Microbes Infect. 2024;26(4):105317. doi: 10.1016/j.micinf.2024.105317

[28] Teh J., Biswas K., Waldvogel-Thurlow S., et al. Paired qualitative and quantitative analysis of bacterial microcolonies in the tonsils of patients with tonsillar hyperplasia // Microbes Infect. 2024. Vol. 26, N 4. P. 105317 doi: 10.1016/j.micinf.2024.105317

[29] Drachuk AI, Nesterova KI, Klyuyev VI, et al. Ultrasound methods in otorhinolaryngology. Omsk; 2007. 49 p. (In Russ.)

[30] Драчук А.И., Нестерова К.И., Клюев В.И., и др. Ультразвуковые методы в оториноларингологии. Омск, 2007. 49 c.

[31] Karpischenko SA, Kolesnikova OM, Legkova YuV. Clinical course of chronic tonsillitis in patients with IgA nephropathy. Russian Medical Journal. 2020;5:13–16. EDN: DGEOCT

[32] Карпищенко С.А., Колесникова О.М., Легкова Ю.В. Клиническое течение хронического тонзиллита у пациентов с IgA-нефропатией // Русский медицинский журнал. 2020. Т. 5. С. 13–16. EDN: DGEOCT

[33] Enya T, Miyazaki K, Miyazawa T, et al. Early tonsillectomy for severe immunoglobulin A nephropathy significantly reduces proteinuria. Pediatr Int. 2020;62(9):1054–1057. doi: 10.1111/ped.14264

[34] Enya T., Miyazaki K., Miyazawa T., et al. Early tonsillectomy for severe immunoglobulin A nephropathy significantly reduces proteinuria // Pediatr Int. 2020. Vol. 62, N 9. P. 1054–1057. doi: 10.1111/ped.14264

[35] Hirano K, Matsuzaki K, Yasuda T, et al. Association between tonsillectomy and outcomes in patients with immunoglobulin a nephropathy. JAMA Netw Open. 2019;2(5):e194772. doi: 10.1001/jamanetworkopen.2019.4772

[36] Hirano K., Matsuzaki K., Yasuda T., et al. Association between tonsillectomy and outcomes in patients with immunoglobulin a nephropathy // JAMA Netw Open. 2019. Vol. 2, N 5. P. e194772. doi: 10.1001/jamanetworkopen.2019.4772

[37] Duan J, Liu D, Duan G, Liu Z. Long-term efficacy of tonsillectomy as a treatment in patients with IgA nephropathy: A meta-analysis. Int Urol Nephrol. 2016;49(1):103–112. doi: 10.1007/s11255-016-1432-7

[38] Duan J., Liu D., Duan G., Liu Z. Long-term efficacy of tonsillectomy as a treatment in patients with IgA nephropathy: A meta-analysis // Int Urol Nephrol. 2016. Vol. 49, N 1. P. 103–112. doi: 10.1007/s11255-016-1432-7

[39] Li Y, Wan Q, Lan Z, et al. Efficacy and indications of tonsillectomy in patients with IgA nephropathy: a retrospective study. Peer J. 2022;10:14481. doi: 10.7717/peerj.14481

[40] Li Y., Wan Q., Lan Z., et al. Efficacy and indications of tonsillectomy in patients with IgA nephropathy: a retrospective study // Peer J. 2022. Vol. 10. P. 14481. doi: 10.7717/peerj.14481

[41] Komatsu H, Sato Y, Miyamoto T, et al. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria. Clin Exp Nephrol. 2015;20(1):94–102. doi: 10.1007/s10157-015-1138-7

[42] Komatsu H., Sato Y., Miyamoto T., et al. Significance of tonsillectomy combined with steroid pulse therapy for IgA nephropathy with mild proteinuria // Clin Exp Nephrol. 2015. Vol. 20, N 1. P. 94–102. doi: 10.1007/s10157-015-1138-7

[43] Neugut YD, Kiryluk K. Genetic determinants of IgA nephropathy: Western Perspective. Semin Nephrol. 2018;38(5):443–454. doi: 10.1016/j.semnephrol.2018.05.014

[44] Neugut Y.D., Kiryluk K. Genetic determinants of IgA nephropathy: Western Perspective // Semin Nephrol. 2018. Vol. 38, N 5. P. 443–454. doi: 10.1016/j.semnephrol.2018.05.014

[45] Feehally J, Coppo R, Troyanov S, et al. Tonsillectomy in a European cohort of 1,147 patients with IGA nephropathy. Nephron. 2016;132(1):15–24. doi: 10.1159/000441852

[46] Feehally J., Coppo R., Troyanov S., et al. Tonsillectomy in a European cohort of 1,147 patients with IGA nephropathy // Nephron. 2016. Vol. 132, N 1. P. 15–24. doi: 10.1159/000441852

[47] Legkova YuV, Kolesnikova OM, Karpishchenko SA. Tactics of treatment of chronic tonsillitis in patients with IgA nephropathy. Folia otorhinolaryngologiae et pathologiae respiratoriae. 2022;28(2):4–10. EDN: WSOHVV doi: 10.33848/foliorl23103825-2022-28-2-4-10

[48] Легкова Ю.В., Колесникова О.М., Карпищенко С.А. Тактика лечения хронического тонзиллита у пациентов с IgA-нефропатией // Folia otorhinolaryngologiae et pathologiae respiratoriae. 2022. Т. 28, № 2. С. 4–10. EDN: WSOHVV doi: 10.33848/foliorl23103825-2022-28-2-4-10

[49] Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 guideline for the management of Glomerular Diseases. Kidney Int. 2021;100(4):753–779. doi: 10.1016/j.kint.2021.05.015

[50] Rovin B.H., Adler S.G., Barratt J., et al. Executive summary of the KDIGO 2021 guideline for the management of Glomerular Diseases // Kidney Int. 2021. Vol. 100, N 4. P. 753–779. doi: 10.1016/j.kint.2021.05.015

[51] Yuzawa Y, Yamamoto R, Takahashi K, et al. Evidence-based clinical practice guidelines for IgA nephropathy 2014. Clin Exp Nephrol. 2016;20(4):511–535. doi: 10.1007/s10157-015-1223-y

[52] Yuzawa Y., Yamamoto R., Takahashi K., et al. Evidence-based clinical practice guidelines for IGA nephropathy 2014 // Clin Exp Nephrol. 2016. Vol. 20, N 4. P. 511–535. doi: 10.1007/s10157-015-1223-y

[53] Shilov EM, Bobkova IN, Kolina IB, Kamishova ES. Clinical recommendations for diagnostics and treatment of IgA-nephropathy. Nephrology. 2015;19(6):83–92. EDN: UZFZCH

[54] Шилов Е.М., Бобкова И.Н., Колина И.Б., Камышова Е.С. Клинические рекомендации по диагностике и лечению IgA-нефропатии // Нефрология. 2015. Т. 19, № 6. С. 83–92. EDN: UZFZCH

[55] Davin J-C, Coppo R. Henoch–Schönlein purpura nephritis in children. Nat Rev Nephrol. 2014;10(10):563–573. doi: 10.1038/nrneph.2014.126

[56] Davin J.-C., Coppo R. Henoch–Schönlein purpura nephritis in children // Nat Rev Nephrol. 2014. Vol. 10, N 10. P. 563–573. doi: 10.1038/nrneph.2014.126

[57] Nicoara O, Twombley K. Immunoglobulin A nephropathy and immunoglobulin A vasculitis. Pediatr Clin North Am. 2019;66(1):101–110. doi: 10.1016/j.pcl.2018.08.008

[58] Nicoara O., Twombley K. Immunoglobulin A nephropathy and immunoglobulin A vasculitis // Pediatr Clin North Am. 2019. Vol. 66, N 1. P. 101–110. doi: 10.1016/j.pcl.2018.08.008

[59] Li X, Tang M, Yao X, et al. A clinicopathological comparison between IGA nephropathy and Henoch–Schönlein purpura nephritis in children: Use of the Oxford Classification. Clin Exp Nephrol. 2019;23(12):1382–1390. doi: 10.1007/s10157-019-01777-8

[60] Li X., Tang M., Yao X., et al. A clinicopathological comparison between IGA nephropathy and Henoch–Schönlein purpura nephritis in children: Use of the Oxford Classification // Clin Exp Nephrol. 2019. Vol. 23, N 12. P. 1382–1390. doi: 10.1007/s10157-019-01777-8

[61] Inoue CN, Chiba Y, Morimoto T, et al. Tonsillectomy in the treatment of pediatric Henoch-Schönlein nephritis. Clin Nephrol. 2007;67(5):298–305. doi: 10.5414/cnp67298

[62] Inoue C.N., Chiba Y., Morimoto T., et al. Tonsillectomy in the treatment of pediatric Henoch-Schönlein nephritis // Clin Nephrol. 2007. Vol. 67, N 5. P. 298–305. doi: 10.5414/cnp67298

[63] Kanai H, Sawanobori E, Kobayashi A, et al. Early treatment with methylprednisolone pulse therapy combined with tonsillectomy for heavy Proteinuric Henoch-Schönlein purpura nephritis in children. Nephron Extra. 2011;1(1):101–111. doi: 10.1159/000333010

[64] Kanai H., Sawanobori E., Kobayashi A., et al. Early treatment with methylprednisolone pulse therapy combined with tonsillectomy for heavy Proteinuric Henoch-Schönlein purpura nephritis in children // Nephron Extra. 2011. Vol. 1, N 1. P. 101–111. doi: 10.1159/000333010

[65] Yan M, Wang Z, Niu N, et al. Relationship between chronic tonsillitis and Henoch-Schonlein purpura. Int J Clin Exp Med. 2015;8(8):14060–14064.

[66] Yan M., Wang Z., Niu N., et al. Relationship between chronic tonsillitis and Henoch-Schonlein purpura // Int J Clin Exp Med. 2015. Vol. 8, N 8. P. 14060–14064.

[67] Hetland L, Susrud K, Lindahl K, Bygum A. Henoch-Schönlein Purpura: a literature review. Acta Derm Venereol. 2017;97(10):1160–1166. doi: 10.2340/00015555-2733

[68] Hetland L., Susrud K., Lindahl K., Bygum A. Henoch-Schönlein Purpura: A literature review // Acta Derm Venereol. 2017. Vol. 97, N 10. P. 1160–1166. doi: 10.2340/00015555-2733

[69] Ohara S, Kawasaki Y, Matsuura H, et al. Successful therapy with tonsillectomy for severe ISKDC Grade VI Henoch–Schönlein purpura nephritis and persistent nephrotic syndrome. Clin Exp Nephrol. 2011;15(5):749–753. doi: 10.1007/s10157-011-0463-8

[70] Ohara S., Kawasaki Y., Matsuura H., et al. Successful therapy with tonsillectomy for severe ISKDC Grade VI Henoch–Schönlein purpura nephritis and persistent nephrotic syndrome // Clin Exp Nephrol. 2011. Vol. 15, N 5. P. 749–753. doi: 10.1007/s10157-011-0463-8

[71] Kawasaki Y, Suyama K, Matsumoto A, et al. Efficacy of tonsillectomy plus methylprednisolone pulse therapy for a child with Henoch-Schoenlein purpura nephritis. Tohoku J Exp Med. 2007;211(3):291–295. doi: 10.1620/tjem.211.291

[72] Kawasaki Y., Suyama K., Matsumoto A., et al. Efficacy of tonsillectomy plus methylprednisolone pulse therapy for a child with Henoch-Schoenlein purpura nephritis // Tohoku J Exp Med. 2007. Vol. 211, N 3. P. 291–295. doi: 10.1620/tjem.211.291

[73] Yamakawa T, Yamamoto I, Komatsuzaki Y, et al. Successful treatment of recurrent Henoch–Schönlein purpura nephritis in a renal allograft with tonsillectomy and steroid pulse therapy. Nephrology. 2016;21(S1):53–56. doi: 10.1111/nep.12770

[74] Yamakawa T., Yamamoto I., Komatsuzaki Y., et al. Successful treatment of recurrent Henoch–Schönlein purpura nephritis in a renal allograft with tonsillectomy and steroid pulse therapy // Nephrology. 2016. Vol. 21, N S1. P. 53–56. doi: 10.1111/nep.12770

[75] Umeda C, Fujinaga S, Endo A, et al. Preventive effect of tonsillectomy on recurrence of Henoch-Schönlein purpura nephritis after intravenous methylprednisolone pulse therapy. Tohoku J Exp Med. 2020;250(1):61–69. doi: 10.1620/tjem.250.61

[76] Umeda C., Fujinaga S., Endo A., et al. Preventive effect of tonsillectomy on recurrence of Henoch-Schönlein purpura nephritis after intravenous methylprednisolone pulse therapy // Tohoku J Exp Med. 2020. Vol. 250, N 1. P. 61–69. doi: 10.1620/tjem.250.61

RIGHTS & PERMISSIONS

Folia Otorhinolaryngologiae et Pathologiae Respiratoriae